133 results
Page 5 of 7
424B5
z70c4kuhoj2y
9 Dec 20
Prospectus supplement for primary offering
4:02pm
424B5
awz77i334e7t
7 Dec 20
Prospectus supplement for primary offering
4:10pm
8-K
EX-99.1
8uf8xn
7 Dec 20
Regulation FD Disclosure
3:45pm
8-K
w6tvtmvt
7 Dec 20
Regulation FD Disclosure
3:45pm
8-K
807h4u0pmn
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.1
2dpa17i
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.2
6t8u019ibq18t
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.1
d8ps2ul
5 Nov 20
Sutro Biopharma Reports Third Quarter 2020 Financial Results
7:05am
8-K
EX-99.2
xyqeloyg61b5tg5ivjh
9 Sep 20
Other Events
5:23pm
8-K
EX-99.1
ezq28shv 5sf
9 Sep 20
Other Events
5:23pm
8-K
EX-99.1
3h03d2fk
6 Aug 20
Sutro Biopharma Reports Second Quarter 2020 Financial Results
7:03am
8-K
EX-99.1
8admy
15 Jun 20
Regulation FD Disclosure
7:21am
8-K
EX-1.1
50oebby8 c5ochx
12 May 20
Entry into a Material Definitive Agreement
5:14pm
424B5
3k0fwpar
12 May 20
Prospectus supplement for primary offering
5:02pm
8-K
EX-99.1
lp72taxi44a3q
11 May 20
Sutro Biopharma Reports First Quarter 2020 Financial Results
4:27pm
424B5
xpowzab
11 May 20
Prospectus supplement for primary offering
4:12pm